In this episode presented by PII, BioSpace’s head of insights discusses decentralized clinical studies and how connected technology can improve patient compliance with guests Oliver Eden and Travis Webb.
> Listen on Spotify
> Listen on Apple Podcasts
> Listen on Amazon Music
> Listen on iHeart
This episode continues the discussion with Oliver Eden, senior business unit director at Jabil, and Travis Webb, chief scientific officer at PII, as they dive into the nuance, challenges and opportunities of autoinjectors and combination drug delivery systems.
In this conversation they focus on supporting decentralized clinical studies and how connected technology can improve patient compliance, trust and cleaner data processing.
This episode is presented in partnership with PII.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Oliver Eden, Senior Business Unit Director, Jabil
Travis Webb, Chief Scientific Officer, PII
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
